Comparison the Long-Term Clinical Outcomes between Non Anti-TNF Versus Anti-TNF in RA Patients Who Failed to a First Anti-TNF

被引：0
|
作者：
Bogas, Patricia [1 ]
Plasencia-Rodriguez, Chamaida [1 ]
Balsa, Alejandro [1 ]
Navarro-Compan, Victoria [2 ]
Bonilla, Gema [1 ]
Moral Coro, Enrique [1 ]
Tornero, Carolina [1 ]
Nuno, Laura [1 ]
Peiteado, Diana [3 ]
机构：
[1] Hosp Univ La Paz, Madrid, Spain
[2] Hosp Univ La Paz, Rheumatol, Madrid, Spain
[3] La Paz Univ Hosp, Rheumatol, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2487
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ANTI-TNFα ANTIBODY VERSUS NON-ANTI-TNFα MOLECULAR AGENTS FOR ULCERATIVE COLITIS PATIENTS WHO FAILED INITIAL ANTI-TNFα THERAPY
    Kanayama, Kengo
    Kato, Jun
    Shiratori, Wataru
    Nagashima, Ariki
    Ohta, Yuki
    Taida, Takashi
    Saito, Keiko
    Goto, Chihiro
    Kurosugi, Akane
    Ishikawa, Tsubasa
    Kaneko, Tatsuya
    Akizue, Naoki
    Okimoto, Kenichiro
    Matsumura, Tomoaki
    Kato, Naoya
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1098 - S1098
  • [2] Anti-TNFα antibody versus non-anti-TNFα molecular agents for ulcerative colitis patients who failed initial anti-TNFα therapy
    Kanayama, Kengo
    Kato, Jun
    Shiratori, Wataru
    Nagashima, Ariki
    Ohta, Yuki
    Taida, Takashi
    Saito, Keiko
    Goto, Chihiro
    Takahashi, Satsuki
    Horio, Ryosuke
    Kurosugi, Akane
    Ishikawa, Tsubasa
    Kaneko, Tatsuya
    Akizue, Naoki
    Okimoto, Kenichiro
    Matsumura, Tomoaki
    Kato, Naoya
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (06) : 1083 - 1089
  • [3] Comparison of causes of drug discontinuation between anti-TNF agents and 'non-anti-TNF biologic agents' in anti-TNF inadequate responder RA patients
    Du Pan, S. Martin
    Neto, D.
    Zufferey, P.
    Ciurea, A.
    Ziswiler, H. R.
    Gabay, C.
    Finckh, A.
    [J]. SWISS MEDICAL WEEKLY, 2013, 143 : 5S - 5S
  • [4] Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?
    Alsharqi, Ali
    Parslew, Richard
    Dever, Bernadette
    Arslanian, Victoria
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 (02) : E45 - E46
  • [5] Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?
    Roblin, Xavier
    Verot, Celine
    Paul, Stephane
    Duru, Gerard
    Williet, Nicolas
    Boschetti, Gilles
    Del Tedesco, Emilie
    Peyrin-Biroulet, Laurent
    Phelip, Jean Marc
    Nancey, Stephane
    Flourie, Bernard
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 2078 - 2085
  • [6] Anti-TNF switching: effect on outcomes in patients with RA
    Olsen, Nancy
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (08): : 430 - 431
  • [7] Anti-TNF switching: effect on outcomes in patients with RA
    Nancy Olsen
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 : 430 - 431
  • [8] INCREASED RISK OF ANTI-DRUG ANTIBODIES TO A SECOND ANTI-TNF IN PATIENTS WHO DEVELOPED ANTIBODIES TO THE FIRST ANTI-TNF
    Yanai, Henit A.
    Amir, Shira
    Avni-Biron, Irit
    Perets, Tsachi Tsadok
    Shamir, Raanan
    Dotan, Iris
    Assa, Amit
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S671 - S671
  • [9] Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF
    Yanai, H.
    Amir, S.
    Biron, I. Avni
    Perets, T. Tsadok
    Shamir, R.
    Dotan, I.
    Assa, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S439 - S439
  • [10] Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
    Hyrich, K. L.
    Lunt, M.
    Dixon, W. G.
    Watson, K. D.
    Symmons, D. P. M.
    [J]. RHEUMATOLOGY, 2008, 47 (07) : 1000 - 1005
12345